Bisoprolol fumarate
- CAS No.
- 104344-23-2
- Chemical Name:
- Bisoprolol fumarate
- Synonyms
- BISOPROLOL HEMIFUMARATE;ZEBETA;DETENSIEL;1-[4-[[2-(1-Methylethoxy)ethoxy]methyl]phenoxy]-3-[(1-methylethyl)amino]-2-propanol hemifumarate salt;EMCOR;SOPROL;ISOTEN;CONCOR;Azopsin;Well-bi
- CBNumber:
- CB8371980
- Molecular Formula:
- C22H35NO8
- Molecular Weight:
- 441.52
- MDL Number:
- MFCD00792743
- MOL File:
- 104344-23-2.mol
- MSDS File:
- SDS
| Melting point | 100°C |
|---|---|
| storage temp. | 2-8°C |
| solubility | DMSO: >20 mg/mL |
| form | solid |
| color | white |
| Merck | 14,1295 |
| InChIKey | RZPZLFIUFMNCLY-WLHGVMLRSA-N |
| SMILES | C1(OCC(O)CNC(C)C)C=CC(COCCOC(C)C)=CC=1.C(/C(=O)O)=C\C(=O)O |
| CAS DataBase Reference | 104344-23-2(CAS DataBase Reference) |
| FDA UNII | UR59KN573L |
| NCI Drug Dictionary | bisoprolol fumarate |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Signal word | Warning | |||||||||
| Hazard statements | H302 | |||||||||
| Precautionary statements | P301+P312+P330 | |||||||||
| Hazard Codes | Xn,Xi | |||||||||
| Risk Statements | 22 | |||||||||
| WGK Germany | 3 | |||||||||
| RTECS | UB8390000 | |||||||||
| HazardClass | IRRITANT | |||||||||
| HS Code | 2922190900 | |||||||||
| Toxicity | dog,LDLo,oral,40mg/kg (40mg/kg),BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)SENSE ORGANS AND SPECIAL SENSES: MYDRIASIS (PUPILLARY DILATION): EYELUNGS, THORAX, OR RESPIRATION: OTHER CHANGES,Kiso to Rinsho. Clinical Report. Vol. 23, Pg. 2321, 1989. | |||||||||
| NFPA 704 |
|
Bisoprolol fumarate price More Price(43)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | B2185 | Bisoprolol hemifumarate salt ≥98% (HPLC), solid | 104344-23-2 | 10mg | $166 | 2024-03-01 | Buy |
| Sigma-Aldrich | 1075757 | Bisoprolol fumarate United States Pharmacopeia (USP) Reference Standard | 104344-23-2 | 200mg | $436 | 2024-03-01 | Buy |
| Alfa Aesar | H56014 | Bisoprolol hemifumarate salt, 98% | 104344-23-2 | 25mg | $207.9 | 2023-01-06 | Buy |
| Alfa Aesar | H56014 | Bisoprolol hemifumarate salt, 98% | 104344-23-2 | 100mg | $716.1 | 2023-01-06 | Buy |
| Cayman Chemical | 23827 | Bisoprolol (hemifumarate) ≥98% | 104344-23-2 | 50mg | $32 | 2024-03-01 | Buy |
Bisoprolol fumarate Chemical Properties,Uses,Production
Pharmacological effects
Bisoprolol fumarate is a selective β1-adrenergic receptor blockers. No intrinsic sympathomimetic activity and membrane stabilizing effect. Animal experiments of different models show that affinity for β1-receptor is 11 to 34-fold larger than β2-receptor. The selectivity for β1 receptor is four times of the similar drugs Atenolol. This product plays the role for a long time (24 hours or more), continual application takes good control of symptoms without tolerance phenomenon, with minimal side effects on the respiratory system, no effects on metabolism of fat. it also has a certain degree of block effect for bronchial β2 receptors, but it may only occur at high doses, usually it has no obvious clinical significance.
Indications
Treatment of essential hypertension. As first-line antihypertensive agents, it can be used alone or combined with diuretics and vasodilator drugs.
Angina and myocardial infarction.
Arrhythmias, such as the rapid ventricular arrhythmia, ventricular contraction.
In recent years, bisoprolol fumarate is also tempted used for the treatment of heart failure. It is effective for moderate to severe chronic stable heart failure which previously receiving ACE inhibitors, diuretics and cardiac glycosides medications associated with ventricular systolic dysfunction (ejection fraction ≤35%) .
The above information is edited by the chemicalbook of Tian Ye.
Method and Dosage
Hypertension: The initial dose is 5mg once, 1 times a day. It may be suitable for some patients to start with initial dose of 2.5mg (such as bronchial spasm disease). If the dose of 5 mg one day is not enough for antihypertensive effect , the dose may be increased to 10-20mg one day .
Angina: initial dose of 2.5mg, 1 time a day, the maximum daily dose can not exceed 10mg.
Heart failure: chronic, stable heart failure: it should start from small dose, if it is tolerated, the dose can gradually increasing (doubling the dose every 2-4 weeks) to the maximum tolerated dose or target dose. The maximum recommended target dose is 10mg one day , the starting dose is usually 1/8 of the target dose.
Distinguish
Take appropriate amount of this product powder (about the equivalent of bisoprolol fumarate 20mg), add 4ml water to dissolve, the filtrate is added 1 to 3 drops of potassium permanganate test solution , purple should fade , and brown precipitate forms.
Take right amount of this product powder,it is dissolved in water and form the solution of which 1ml each contains about 0.1mg bisoprolol fumarate,after filtration, take continued filtrate, according to the UV-visible spectrophotometry (Appendix Ⅳ A) measure ,there is the maximum absorption in the 271nm wavelength.
In the chromatogram recorded under the item of content determination ,the test solution peak retention time should be consistent with the reference solution peak retention time.
Content Determine
Take 10 tablets of this product , weigh accurately, porphyrize, accurately weigh appropriate amount (about the equivalent of bisoprolol fumarate 5mg), set it into 50ml volumetric flask, add water to make bisoprolol fumarate dissolve and dilute it to the mark , shake, filtrate, according to chromatographic conditions under the item of bisoprolol fumarate related substances,take the precise amount of continued filtrate 20μl into the liquid chromatograph, record the chromatograms; in addition
Drug interactions
1.when bisoprolol fumarate is used in combination with other anti-hypertensive drugs, the antihypertensive effect is enhanced .
2. when bisoprolol fumarate is used in combination with reserpine, methyldopa, clonidine or guanfacine, the heart rate can be slowed down.
3. when bisoprolol fumarate is used in combination with reserpine, reserpine needs to be stopped a few days after stop of this product .
4. when bisoprolol fumarate is used in combination with nifedipine, the antihypertensive effect of this product can be enhanced .
5. when bisoprolol fumarate is used in combination with verapamil or diltiazem ketones calcium icon antagonists or other antiarrhythmic drugs , there is the need for patient care, because they can cause hypotension, bradycardia and others.
Precautions
Diabetic patients with great blood glucose fluctuations or acidosis patients should be careful in use of it.
Patients with pulmonary insufficiency, severe liver and kidney dysfunction should use with caution.
Interruption of treatment should diminish doses daily ,when it is used in combination with other antihypertensive drugs, the dose often requires reductions.
when drug overdose causes slow heartbeat or low blood pressure , patients must immediately stop taking this product. If necessary, take separate or sequential use of following drugs, atropine 0.5mg~2.0mg intravenously, appropriate amount of metaproterenol slow intravenous injection; glucagon 1mg~5mg (or 1mg~10mg).
Because the antihypertensive effect of bisoprolol fumarate, capacity of the patient to drive or operate the machine may be weakened , particularly at the beginning of taking medication or conversion medication and taking with alcohol at the same time, but the person's ability to respond will not be directly affected .
Side effects
1.In early medication, mild fatigue, chest tightness, dizziness, bradycardia, drowsiness, palpitations, headache and lower limb edema may appear , and all automatically reduce or disappear after continuing taking .
2. In rare cases, there will be gastrointestinal disorders (diarrhea, constipation, nausea, abdominal pain) and skin reactions (eg erythema, itching).
3. Occasionally blood pressure decreases , pulse slow or atrioventricular conduction disorders.
4.Sometimes there will be tingling or cold extremities, in rare cases, it can cause muscle weakness, muscle cramps and less tears.
5.For patients with intermittent claudication or Raynaud's phenomenon,during the initial medication, the condition may worsen, the condition of existing myocardial dysfunction patients will possibly aggravate.
6.Occasionally airway resistance may increase .
7.Elderly patients with diabetes, their glucose tolerance may reduce , which may cover hypoglycemia manifestations (such as rapid heartbeat).
Category
Toxic substances
Toxicity
Moderate poisoning
Acute toxicity
Oral-rat LD50: 940 mg/kg; Oral-Mouse LD50: 678 mg/kg
Flammability hazard characteristics
Combustible; fire decomposition with toxic nitrogen oxide fumes
Storage Characteristics
Treasury temperature, ventilation, dry
Extinguishing agent
Water, carbon dioxide, dry, sandy soil
Description
Bisoprolol fumarate is a β1-selective adrenergic blocker useful in the treatment of essential hypertension.
Chemical Properties
White Solid
Originator
E. Merck (W. Germany)
Uses
Labeled Bisoprolol, intended for use as an internal standard for the quantification of Bisoprolol by GC- or LC-mass spectrometry.
Uses
semi-synthetic kanamycin-derived aminoglycoside antibiotic
Uses
antiinflammatory
Uses
A selective β-adrenergic blocker. Used as an antihypertensive.
Uses
A selective α-adrenergic blocker. Used as an antihypertensive.
Uses
A selective a-adrenergic blocker. Used as an antihypertensive
Manufacturing Process
A solution of 10 g of 1-(p-2-isopropoxyethoxymethylphenoxy)-3-isopropylideneamino-propan-2-ol [obtainable by reacting 1-(p-2- isopropoxyethoxymethylphenoxy)-2,3-epoxy propane with ammonia to give 1- (p-2-isopropoxyethoxymethylphenoxy)-3-amino-propan-2-ol and subsequently reacting this with acetone] in 250 ml of ethanol was hydrogenated on 0.5 g of Raney nickel at 25°C under 1 atmosphere of pressure until 1 equivalent of H2 had been absorbed. The mixture was filtered and the filtrate evaporated to give 1-(p-2-iso-propoxyethoxymethyl-phenoxy)-3-isopropylamino-propan-2-ol, fumarate, m.p. 100°C (after addition of equimolecular quantity of fumaric acid).
brand name
Zebeta (Duramed);CONCOR.
Therapeutic Function
Beta-adrenergic blocker
Biological Activity
A selective β 1 -adrenergic antagonist. Has a K d of 2-3 nM at the β 1 receptor and a β 1 / β 2 selectivity of approximately 100-fold.
Biochem/physiol Actions
Bisoprolol hemifumarate is useful in oral formulations due to its high bioavailability. It also shows long elimination half-life.
Clinical Use
Beta-1 adrenoceptor blocker:
Hypertension
Angina
Adjunctive treatment for heart failure
Drug interactions
Potentially hazardous interactions with other drugs
Anaesthetics: enhanced hypotensive effect.
Analgesics: NSAIDs antagonise hypotensive effect.
Anti-arrhythmics: increased risk of myocardial
depression and bradycardia; increased risk of
bradycardia, myocardial depression and AV block
with amiodarone; increased risk of myocardial
depression and bradycardia with flecainide.
Antibacterials: concentration reduced by rifampicin.
Antidepressants: enhanced hypotensive effect with
MAOIs.
Antihypertensives; enhanced hypotensive effect;
increased risk of withdrawal hypertension with
clonidine; increased risk of first dose hypotensive
effect with post-synaptic alpha-blockers such as
prazosin.
Antimalarials: increased risk of bradycardia with
mefloquine.
Antipsychotics enhanced hypotensive effect with
phenothiazines.
Calcium-channel blockers: increased risk of
bradycardia and AV block with diltiazem;
hypotension and heart failure possible with
nifedipine and nisoldipine; asystole, severe
hypotension and heart failure with verapamil.
Cytotoxics: possible increased risk of bradycardia
with crizotinib.
Diuretics: enhanced hypotensive effect.
Fingolimod: possibly increased risk of bradycardia.
Moxisylyte: possible severe postural hypotension.
Sympathomimetics: severe hypertension with
adrenaline and noradrenaline, and possibly with
dobutamine.
Metabolism
Bisoprolol is excreted from the body by two routes. 50% is metabolised by the liver to inactive metabolites which are then excreted by the kidneys. The remaining 50% is excreted by the kidneys in an unmetabolised form.
Bisoprolol fumarate Preparation Products And Raw materials
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Zibo Wei Bin Import & Export Trade Co. Ltd. | +86-0533-2091136 +8613864437655 | ziboweibinmaoyi@163.com | China | 100 | 58 |
| Wuhan Fortuna Chemical Co., Ltd | +86-027-59207850 | info@fortunachem.com | China | 5975 | 58 |
| Henan Bao Enluo International TradeCo.，LTD | +86-17331933971 +86-17331933971 | deasea125996@gmail.com | China | 2472 | 58 |
| ShenZhen H&D Pharmaceutical Technology Co., LTD | +8618627948422 | sale@hdimpurity.com | China | 3389 | 58 |
| Beijing Cooperate Pharmaceutical Co.,Ltd | 010-60279497 | sales01@cooperate-pharm.com | CHINA | 1803 | 55 |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 | info@tianfuchem.com | China | 21634 | 55 |
| Hangzhou FandaChem Co.,Ltd. | +8615858145714 | FandaChem@Gmail.com | China | 9116 | 55 |
| Hubei XinRunde Chemical Co., Ltd. | +8615102730682 | bruce@xrdchem.cn | CHINA | 566 | 55 |
| ATK CHEMICAL COMPANY LIMITED | +undefined-21-51877795 | ivan@atkchemical.com | China | 32957 | 60 |
| career henan chemical co | +86-0371-86658258 +8613203830695 | sales@coreychem.com | China | 29880 | 58 |
Related articles
- Bisoprolol fumarate: Indications, Mechanism of Action and Side Effects
- Bisoprolol fumarate is the active ingredient in the prescription drug Bisoprolol, which belongs to the class of drugs known as....
- Dec 16，2024
- Bisoprolol Fumarate: Clinical Pharmacology and Detection Method
- Bisoprolol Fumarate, a selective beta-1 blocker for hypertension and heart failure, is evaluated for stability and compatibili....
- Sep 23，2024
- Synthesis and Detection method of Bisoprolol fumarate
- Bisoprolol fumarate is used to treat conditions such as hypertension and angina pectoris.
- Aug 29，2022
View Lastest Price from Bisoprolol fumarate manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2024-12-13 | Bisoprolol fumarate
104344-23-2
|
US $0.00-0.00 / KG | 1KG | 99.0%~101.0%; EP10.0 | 1500kg/month | WUHAN FORTUNA CHEMICAL CO., LTD | |
 |
2024-11-14 | Bisoprolol fumarate
104344-23-2
|
US $596.00 / KG | 1KG | 99% | 1T | Baoji Guokang Bio-Technology Co., Ltd. | |
 |
2024-09-20 | Bisoprolol(Fumarate)
104344-23-2
|
US $0.00-0.00 / mg | 10mg | 98% | 500mg | ShenZhen H&D Pharmaceutical Technology Co., LTD |
-
- Bisoprolol fumarate
104344-23-2
- US $0.00-0.00 / KG
- 99.0%~101.0%; EP10.0
- WUHAN FORTUNA CHEMICAL CO., LTD
-
- Bisoprolol fumarate
104344-23-2
- US $596.00 / KG
- 99%
- Baoji Guokang Bio-Technology Co., Ltd.
-
- Bisoprolol(Fumarate)
104344-23-2
- US $0.00-0.00 / mg
- 98%
- ShenZhen H&D Pharmaceutical Technology Co., LTD
104344-23-2(Bisoprolol fumarate)Related Search:
1of4